Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma

Overview of attention for article published in Biomarker Research, July 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 11,971 followers.

RT @CARTTherapy: Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma https://t.co/buyZyVKWxQ #CART #bmtsm…

RT @CARTTherapy: Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma https://t.co/buyZyVKWxQ #CART #bmtsm…

RT @CARTTherapy: Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma https://t.co/buyZyVKWxQ #CART #bmtsm…

RT @CARTTherapy: Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma https://t.co/buyZyVKWxQ #CART #bmtsm…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.